<!DOCTYPE html>
<html lang="en">
<head id="Head1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta http-equiv="content-type" content="text/html;charset=utf-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=Edge" />
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Full Text of HB1018</title>
    <link rel="shortcut icon" type="image/x-icon" href="https://cdn.ilga.gov/assets/img/site/favicon.ico" />
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap.min.css" />
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <script src="https://cdn.ilga.gov/assets/js/fontawesome/fa.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/jquery.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/js.cookie.min.js"></script>
    <script async src="https://cse.google.com/cse.js?cx=a47f92b5e11c1499a"></script> 
    <!-- Bootstrap Datepicker CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap-datepicker.min.css">
    <!-- Bootstrap Datepicker JavaScript -->
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap-datepicker.min.js"></script>
    <!-- aos, bootstrap icons, swiper CSS -->
    <link href="https://cdn.ilga.gov/assets/css/aos/aos.css" rel="stylesheet">
    <link href="https://cdn.ilga.gov/assets/css/swiper/swiper-bundle.min.css" rel="stylesheet">

    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.js"></script>

    <!-- ILGA main CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/main.css" />
    <link rel="stylesheet" type="text/css" media="print" href="https://cdn.ilga.gov/assets/css/print.css">
    <style></style>
    
</head>
<body>
        <!-- ======= Header ======= -->
        <header id="print-header" class="d-flex align-items-center">
            <div class="container-fluid align-items-center text-uppercase justify-content-start ">
                <div class="logo ">
                    <a href="/"><img src="https://cdn.ilga.gov/assets/img/site/white_capitol.png" alt="ILGA Logo"><span>ILGA.GOV</span></a>
                </div>
                <div class="w-100"></div>
            </div>
        </header>
    <input id="TextSearch" type="hidden" />
    <input id="MobileTextSearch" type="hidden" />
    <input id="message-input" type="hidden" />

    <main id="main-content" role="main">
        <section class="main-page p-2">
	<div class="p-1 pt-4 float-left">
		<div class="row border-bottom pb-3 mb-3">
			<div class="text-start">
				<h2>
					HB1018 - 104th General Assembly
				</h2><br />
			</div>
		</div>
		<div id="content">
			<!-- Full text only shows on large screens -->
			<div class="centered-container d-lg-flex">
				<div class="left-aligned-content">
					<div class="row">
						<div class="col pl-lg-5" translate="no">
							<text class="ml-5 text-left fulltextLineHeight" id="billtextanchor">
								<style>
								
								
								
								table.xsl	{ 	border-collapse: collapse;
												border: 0px solid black;
												font-family: "courier New"; 
												font-size: 10pt;}
								
								td.xsl		{ 	border-collapse: collapse;
												border: 0px solid black;
												padding-top: 3pt;
												padding-bottom: 3pt;
												padding-left: 0pt;
												padding-right: 0pt;
												font-family: "courier New"; 
												font-size: 10pt; }
												
								td.junk		{ 	width: 5%; }
								 
							
					
					
						body.xsl		{ 	text-align:center; }
						
					
						td.lineNum 		{ 	vertical-align: top; 
										  	text-align: right;
										  	font-family: "courier New"; 
										  	font-size: 10pt; }
							
						td.number 		{	width: 5%;
											vertical-align: top; 
										  	text-align: right;
										  	font-family: "Courier New", sans-serif;
										  	font-size: 10pt; }
						
						td.synopsis		{ 	border-collapse: collapse;
											border: 0px solid black;
											padding-top: 0pt;
											padding-bottom: 0pt;
											padding-left: 0pt;
											padding-right: 0pt;
											font-family: "courier New"; 
											font-size: 10pt; }
						
						td.rowsep		{ 	border-bottom: 1px solid black; }
											
						td.colsep		{ 	border-right: 1px solid black; }
											
						td.bothsep		{ 	border-right: 1px solid black;
										  	border-bottom: 1px solid black; }
	
						table.top		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black; }
											
						table.bottom	{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-bottom: 1px solid black; }
											
						table.sides		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black; }
	
						table.all		{ 	font-family: "Courier New", sans-serif;
										  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black;
									  	  	border-bottom: 1px solid black;
									  	  	border-top: 1px solid black; }				
	
						table.topbot	{ 	border-collapse: separate;
									  	  	border: outset 0pt;
										  	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black;
									  	  	border-bottom: 1px solid black; }
					
						.sigline		{ 	text-align: left;
							 		 		vertical-align: bottom;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.siglinetext		{ 	text-align: left;
							 		 		vertical-align: top;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.sigtitle		{ 	text-align: left;
							 				vertical-align: top;
							 				padding: 0pt; }
							 				  
						.sigtitlenum		{ 	text-align: right;
							 				vertical-align: top;
							 				padding: 0pt; }
							
						.siglinenum		{ 	text-align: right;
							 				vertical-align: center;
							 				padding-top: 3pt;
							 				padding: 0pt; }
					</style><table class="xsl" width="578"><pre><tr><td class="xsl" colspan="3"><p> </p><br> </td></tr></td></tr><tr><td class="number"></td><td class="junk"></td><td class="xsl"><table class="xsl" width="100%"><tr><td class="xsl"><center><b><pre><font size="3" face="Courier New">104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026</font><br>HB1018</pre></b></center><p> </p>Introduced 1/9/2025, by Rep. John M. Cabello<p> </p><b>SYNOPSIS AS INTRODUCED:</b><br> </td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl"><table class="xsl" width="100%"><colgroup width="50%"></colgroup><colgroup width="50%"></colgroup><tr><td class="synopsis"><code>215 ILCS 5/513b1</code></td><td class="synopsis"></td></tr></table><p></p></td></tr><tr><td class="xsl"><code>    </code><code>Amends the Illinois Insurance Code. Provides that a pharmacy benefit </code><code>manager or an affiliate acting on the pharmacy benefit manager's behalf is </code><code>prohibited from steering a covered individual. Defines "steer". Effective </code><code>July 1, 2025.</code></td></tr><tr align="right" class="lineNum"><td class="xsl"><br><br></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left"></td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 03422 BAB 13444 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl"><p> </p><p> </p><center><b>A BILL FOR</b></center><p></p></td></tr></table><p> </p></td></tr><tr><td class="xsl"></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB1018</td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 03422 BAB 13444 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>AN ACT concerning regulation.</code><br> </td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><b><code>Be it enacted by the People of the State of Illinois, </code></b></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><b><code>represented in the General Assembly:</code></b><br> </td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 5. </code><code>The Illinois Insurance Code is amended by </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>changing Section 513b1 as follows:</code><br> </td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(215 ILCS 5/513b1)</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Sec. 513b1. </code><code>Pharmacy benefit manager contracts.</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) As used in this Section: </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"340B drug discount program" means the program established </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>under Section 340B of the federal Public Health Service Act, </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>42 U.S.C. 256b. </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"340B entity" means a covered entity as defined in 42 </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>U.S.C. 256b(a)(4) authorized to participate in the 340B drug </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>discount program. </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"340B pharmacy" means any pharmacy used to dispense 340B </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>drugs for a covered entity, whether entity-owned or external. </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Biological product" has the meaning ascribed to that term </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>in Section 19.5 of the Pharmacy Practice Act. </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Maximum allowable cost" means the maximum amount that a </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>pharmacy benefit manager will reimburse a pharmacy for the </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>cost of a drug. </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Maximum allowable cost list" means a list of drugs for </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>which a maximum allowable cost has been established by a </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB1018</td><td class="xsl" align="center">- 2 -</td><td class="xsl" align="right">LRB104 03422 BAB 13444 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>pharmacy benefit manager. </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Pharmacy benefit manager" means a person, business, or </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>entity, including a wholly or partially owned or controlled </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>subsidiary of a pharmacy benefit manager, that provides claims </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>processing services or other prescription drug or device </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>services, or both, for health benefit plans. </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Retail price" means the price an individual without </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>prescription drug coverage would pay at a retail pharmacy, not </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>including a pharmacist dispensing fee. </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>"Steer" includes, but is not limited to:</code></u></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(1) requiring a covered individual to use only a </code></u></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <u><code>pharmacy, including a mail-order pharmacy, in which the </code></u></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <u><code>pharmacy benefit manager maintains an ownership interest </code></u></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <u><code>or control;</code></u></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(2) offering or implementing a plan design that </code></u></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <u><code>encourages a covered individual to use a pharmacy in which </code></u></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <u><code>the pharmacy benefit manager maintains an ownership </code></u></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <u><code>interest or control, if such plan design increases costs </code></u></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <u><code>for the covered individual, including requiring a covered </code></u></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <u><code>individual to pay full costs for a prescription if the </code></u></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <u><code>covered individual chooses not to use a pharmacy owned or </code></u></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <u><code>controlled by the pharmacy benefit manager;</code></u></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(3) reimbursing a pharmacy or pharmacist for a </code></u></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <u><code>pharmaceutical product or pharmacist service in an amount </code></u></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <u><code>less than the amount that the pharmacy benefit manager </code></u></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <u><code>reimburses itself or an affiliate for providing the same </code></u></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB1018</td><td class="xsl" align="center">- 3 -</td><td class="xsl" align="right">LRB104 03422 BAB 13444 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <u><code>product or services, unless the pharmacy or pharmacist </code></u></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <u><code>contractually agrees to a lower reimbursement amount; or</code></u></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><u><code>(4) any other actions determined by the Department by </code></u></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <u><code>rule.</code></u><code> </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Third-party payer" means any entity that pays for </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>prescription drugs on behalf of a patient other than a health </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>care provider or sponsor of a plan subject to regulation under </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>Medicare Part D, 42 U.S.C. 1395w-101 et seq. </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) A contract between a health insurer and a pharmacy </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>benefit manager must require that the pharmacy benefit </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>manager: </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) Update maximum allowable cost pricing information </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>at least every 7 calendar days. </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) Maintain a process that will, in a timely manner, </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>eliminate drugs from maximum allowable cost lists or </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>modify drug prices to remain consistent with changes in </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>pricing data used in formulating maximum allowable cost </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>prices and product availability. </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) Provide access to its maximum allowable cost list </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>to each pharmacy or pharmacy services administrative </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>organization subject to the maximum allowable cost list. </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>Access may include a real-time pharmacy website portal to </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>be able to view the maximum allowable cost list. As used in </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>this Section, "pharmacy services administrative </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>organization" means an entity operating within the State </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>that contracts with independent pharmacies to conduct </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB1018</td><td class="xsl" align="center">- 4 -</td><td class="xsl" align="right">LRB104 03422 BAB 13444 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>business on their behalf with third-party payers. A </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>pharmacy services administrative organization may provide </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>administrative services to pharmacies and negotiate and </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>enter into contracts with third-party payers or pharmacy </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>benefit managers on behalf of pharmacies. </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) Provide a process by which a contracted pharmacy </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>can appeal the provider's reimbursement for a drug subject </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>to maximum allowable cost pricing. The appeals process </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>must, at a minimum, include the following: </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(A) A requirement that a contracted pharmacy has </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >        <code>14 calendar days after the applicable fill date to </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >        <code>appeal a maximum allowable cost if the reimbursement </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >        <code>for the drug is less than the net amount that the </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >        <code>network provider paid to the supplier of the drug. </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(B) A requirement that a pharmacy benefit manager </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >        <code>must respond to a challenge within 14 calendar days of </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >        <code>the contracted pharmacy making the claim for which the </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >        <code>appeal has been submitted.</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(C) A telephone number and e-mail address or </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >        <code>website to network providers, at which the provider </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >        <code>can contact the pharmacy benefit manager to process </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >        <code>and submit an appeal.</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(D) A requirement that, if an appeal is denied, </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >        <code>the pharmacy benefit manager must provide the reason </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >        <code>for the denial and the name and the national drug code </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >        <code>number from national or regional wholesalers.</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB1018</td><td class="xsl" align="center">- 5 -</td><td class="xsl" align="right">LRB104 03422 BAB 13444 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>    </code><code>(E) A requirement that, if an appeal is sustained, </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >        <code>the pharmacy benefit manager must make an adjustment </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >        <code>in the drug price effective the date the challenge is </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >        <code>resolved and make the adjustment applicable to all </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >        <code>similarly situated network pharmacy providers, as </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >        <code>determined by the managed care organization or </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >        <code>pharmacy benefit manager. </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(5) Allow a plan sponsor contracting with a pharmacy </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>benefit manager an annual right to audit compliance with </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>the terms of the contract by the pharmacy benefit manager, </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>including, but not limited to, full disclosure of any and </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>all rebate amounts secured, whether product specific or </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>generalized rebates, that were provided to the pharmacy </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>benefit manager by a pharmaceutical manufacturer.</code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(6) Allow a plan sponsor contracting with a pharmacy </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>benefit manager to request that the pharmacy benefit </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>manager disclose the actual amounts paid by the pharmacy </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>benefit manager to the pharmacy.</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(7) Provide notice to the party contracting with the </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>pharmacy benefit manager of any consideration that the </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>pharmacy benefit manager receives from the manufacturer </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>for dispense as written prescriptions once a generic or </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>biologically similar product becomes available. </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(c) In order to place a particular prescription drug on a </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>maximum allowable cost list, the pharmacy benefit manager </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>must, at a minimum, ensure that: </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB1018</td><td class="xsl" align="center">- 6 -</td><td class="xsl" align="right">LRB104 03422 BAB 13444 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) if the drug is a generically equivalent drug, it </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>is listed as therapeutically equivalent and </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>pharmaceutically equivalent "A" or "B" rated in the United </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>States Food and Drug Administration's most recent version </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>of the "Orange Book" or have an NR or NA rating by </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>Medi-Span, Gold Standard, or a similar rating by a </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>nationally recognized reference; </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) the drug is available for purchase by each </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>pharmacy in the State from national or regional </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>wholesalers operating in Illinois; and </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) the drug is not obsolete. </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(d) A pharmacy benefit manager is prohibited from limiting </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>a pharmacist's ability to disclose whether the cost-sharing </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>obligation exceeds the retail price for a covered prescription </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>drug, and the availability of a more affordable alternative </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>drug, if one is available in accordance with Section 42 of the </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>Pharmacy Practice Act. </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(e) A health insurer or pharmacy benefit manager shall not </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>require an insured to make a payment for a prescription drug at </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>the point of sale in an amount that exceeds the lesser of: </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) the applicable cost-sharing amount; or</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) the retail price of the drug in the absence of </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>prescription drug coverage. </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(f) Unless required by law, a contract between a pharmacy </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>benefit manager or third-party payer and a 340B entity or 340B </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>pharmacy shall not contain any provision that: </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB1018</td><td class="xsl" align="center">- 7 -</td><td class="xsl" align="right">LRB104 03422 BAB 13444 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) distinguishes between drugs purchased through the </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>340B drug discount program and other drugs when </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>determining reimbursement or reimbursement methodologies, </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>or contains otherwise less favorable payment terms or </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>reimbursement methodologies for 340B entities or 340B </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>pharmacies when compared to similarly situated non-340B </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>entities; </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) imposes any fee, chargeback, or rate adjustment </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >    <code>that is not similarly imposed on similarly situated </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>pharmacies that are not 340B entities or 340B pharmacies; </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) imposes any fee, chargeback, or rate adjustment </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>that exceeds the fee, chargeback, or rate adjustment that </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>is not similarly imposed on similarly situated pharmacies </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>that are not 340B entities or 340B pharmacies; </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) prevents or interferes with an individual's choice </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>to receive a covered prescription drug from a 340B entity </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>or 340B pharmacy through any legally permissible means, </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>except that nothing in this paragraph shall prohibit the </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>establishment of differing copayments or other </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>cost-sharing amounts within the benefit plan for covered </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>persons who acquire covered prescription drugs from a </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>nonpreferred or nonparticipating provider; </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(5) excludes a 340B entity or 340B pharmacy from a </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>pharmacy network on any basis that includes consideration </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>of whether the 340B entity or 340B pharmacy participates </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >    <code>in the 340B drug discount program; </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB1018</td><td class="xsl" align="center">- 8 -</td><td class="xsl" align="right">LRB104 03422 BAB 13444 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(6) prevents a 340B entity or 340B pharmacy from using </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>a drug purchased under the 340B drug discount program; or </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(7) any other provision that discriminates against a </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >    <code>340B entity or 340B pharmacy by treating the 340B entity </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>or 340B pharmacy differently than non-340B entities or </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>non-340B pharmacies for any reason relating to the </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >    <code>entity's participation in the 340B drug discount program. </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>As used in this subsection, "pharmacy benefit manager" and </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>"third-party payer" do not include pharmacy benefit managers </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>and third-party payers acting on behalf of a Medicaid program. </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><u><code>(f-5) A pharmacy benefit manager or an affiliate acting on </code></u></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><u><code>the pharmacy benefit manager's behalf shall not steer a </code></u></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><u><code>covered individual.</code></u></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(g) A violation of this Section by a pharmacy benefit </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>manager constitutes an unfair or deceptive act or practice in </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>the business of insurance under Section 424. </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(h) A provision that violates subsection (f) in a contract </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>between a pharmacy benefit manager or a third-party payer and </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>a 340B entity that is entered into, amended, or renewed after </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>July 1, 2022 shall be void and unenforceable. </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(i)(1) A pharmacy benefit manager may not retaliate </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>against a pharmacist or pharmacy for disclosing information in </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>a court, in an administrative hearing, before a legislative </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>commission or committee, or in any other proceeding, if the </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>pharmacist or pharmacy has reasonable cause to believe that </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>the disclosed information is evidence of a violation of a </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB1018</td><td class="xsl" align="center">- 9 -</td><td class="xsl" align="right">LRB104 03422 BAB 13444 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>State or federal law, rule, or regulation.</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(2) A pharmacy benefit manager may not retaliate against a </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>pharmacist or pharmacy for disclosing information to a </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>government or law enforcement agency, if the pharmacist or </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>pharmacy has reasonable cause to believe that the disclosed </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>information is evidence of a violation of a State or federal </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>law, rule, or regulation.</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(3) A pharmacist or pharmacy shall make commercially </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>reasonable efforts to limit the disclosure of confidential and </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>proprietary information.</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(4) Retaliatory actions against a pharmacy or pharmacist </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>include cancellation of, restriction of, or refusal to renew </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>or offer a contract to a pharmacy solely because the pharmacy </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>or pharmacist has:</code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(A) made disclosures of information that the </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>pharmacist or pharmacy has reasonable cause to believe is </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>evidence of a violation of a State or federal law, rule, or </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>regulation;</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(B) filed complaints with the plan or pharmacy benefit </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>manager; or</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(C) filed complaints against the plan or pharmacy </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>benefit manager with the Department.</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(j) This Section applies to contracts entered into or </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>renewed on or after July 1, 2022. </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(k) This Section applies to any group or individual policy </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>of accident and health insurance or managed care plan that </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB1018</td><td class="xsl" align="center">- 10 -</td><td class="xsl" align="right">LRB104 03422 BAB 13444 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>provides coverage for prescription drugs and that is amended, </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>delivered, issued, or renewed on or after July 1, 2020. </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 102-778, eff. 7-1-22; 103-154, eff. 6-30-23; </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>103-453, eff. 8-4-23.)</code><br> </td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 99. </code><code>Effective date. </code><code>This Act takes effect July 1, </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>2025.</code></pre></table>
							</text>
						</div>
					</div>
				</div>
			</div>
		</div>
    </div>
</section>
    </main>
    <!-- Vendor JS Files -->
    <script src="https://cdn.ilga.gov/assets/js/aos/aos.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/popper.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap.bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/glightbox/glightbox.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/swiper/swiper-bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/main.js"></script>

    

</body>
</html>
